Ultragenyx Pharmaceutical Inc. Class Action Lawsuit

Company: Ultragenyx Pharmaceutical Inc.

Ticker: (NASDAQ) RARE

Class Action Period: August 3, 2023 - December 26, 2025

36 Days LeftLead Plaintiff Deadline: April 6, 2026

See If You Qualify For Monetary Reward

Join the Ultragenyx Pharmaceutical Inc. Class Action Lawsuit

There is no cost or obligation for you to submit.

The submission of this form does not create an attorney-client relationship.

CLASS ACTION PERIOD

August 3, 2023 - December 26, 2025

Allegations

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of setrusumab’s potential and the true risk inherent in the study protocols put forth; notably, that, while setrusumab does increase material bone density, this increase does not correlate to a decrease in annualized fracture rates or otherwise the Phase III Orbit and Cosmic studies were much less likely to be able to demonstrate such a link than management claimed. On December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had not “achieved statistical significance against the primary endpoints of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively.” The Company attributed the study failure to a “low fracture rate in the placebo group” of Orbit and a trend that fell shy of statistical significance in Cosmic. Following this news, the price of Ultragenyx’s common stock declined dramatically. From a closing market price of $34.19 per share on December 26, 2025, Ultragenyx’s stock price fell to $19.72 per share on December 29, 2025, a decline of about 42.32% in the span of just a single day.

Eligibility

Eligibility

To join the lawsuit, you must have experienced a loss on Ultragenyx shares purchased within the class period specified above.

Lead Plaintiff Deadline

Lead Plaintiff Deadline

If you suffered a loss in Ultragenyx Pharmaceutical Inc. during the relevant time frame, you have until April 6, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

EXPLORE MORE CASES

Plug Power Inc.

PLUG

Lead Plaintiff Deadline: April 3, 2026

Class Period: January 17, 2025 - November 13, 2025

33 Days Left

BellRing Brands, Inc.

BRBR

Lead Plaintiff Deadline: March 23, 2026

Class Period: November 19, 2024 - August 4, 2025

22 Days Left

Richtech Robotics Inc.

RR

Lead Plaintiff Deadline: April 3, 2026

Class Period: January 27, 2026 - January 29, 2026

33 Days Left

Case Podcast